Embed

Academic

Authors

Lydia Usha

Lydia Usha,Rush University Medical Center,Oncology,Genetics & Genealogy,Anatomy

Edit

Lydia Usha

Rush University Medical Center

Publications: 6 | Citations: 9

Fields: Oncology, Genetics & Genealogy, Anatomy

Collaborated with 30 co-authors from 2000 to 2011 | Cited by 45 authors

Cumulative Annual

Sort by:

Publications (6)

BibTeX | RIS | RefWorks Download

A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies (Citations: 1)

, , , , , , , , ,

Journal: Gynecologic Oncology - GYNECOL ONCOL , vol. 121, no. 3, pp. 455-461, 2011

Topoisomerase II alpha gene copy loss has adverse prognostic significance in ERBB2-amplified breast cancer: a retrospective study of paraffin-embedded tumor specimens and medical charts (Citations: 2)

, , , , , , ,

Journal: Journal of Hematology & Oncology - J HEMATOL ONCOL , vol. 1, no. 1, pp. 12-10, 2008

Effects ofERBB2 amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancer (Citations: 4)

, , , , , , , ,

Journal: Genes Chromosomes & Cancer - GENE CHROMOSOME CANCER , vol. 46, no. 4, pp. 397-405, 2007

Biclonal Breast Carcinoma Metastatic to a Supraclavicular Lymph Node

, ,

Journal: Breast Journal - BREAST J , vol. 11, no. 6, pp. 488-488, 2005

Identification of downstream targets of the putative tumor suppressor gene on 8p by differential gene expression analysis (Citations: 1)

, , , , ,

Journal: Nature Genetics - NAT GENET , vol. 27, no. 4, pp. 40-40, 2001

Sort by:

Citations (9 times by 9 publications)

Formation and interpretation of the BMP morphogen gradient in the Drosophila embryo

, , , ,

Journal: Developmental Biology - DEVELOP BIOL , vol. 356, no. 1, pp. 207-207, 2011

Topoisomerase 2 Alpha and the Case for Individualized Breast Cancer Therapy (Citations: 1)

, , ,

Journal: Annals of Surgical Oncology - ANNALS SURG ONCOLOGY , vol. 17, no. 5, pp. 1392-1397, 2010

Clinical evaluation of developed PCR-based method with hydrolysis probes for TOP2A copy number evaluation in breast cancer samples

, , , , , ,

Journal: Clinical Biochemistry - CLIN BIOCHEM , vol. 43, no. 10, pp. 891-898, 2010

GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer (Citations: 18)

, , , ,

Journal: Oncogene , vol. 28, no. 2, pp. 195-208, 2009

Predicting the efficacy of trastuzumab-based therapy in breast cancer: Current standards and future strategies (Citations: 12)

, ,

Journal: Biochimica Et Biophysica Acta-reviews on Cancer - BBA-REV CANCER , vol. 1786, no. 2, pp. 105-113, 2008

Comments

Co-authors (30)

Journals (6)

Keywords (18)

Lydia Usha,Rush University Medical Center,Oncology,Genetics & Genealogy,Anatomy

Publications (6)

BibTeX | RIS | RefWorks Download

A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies (Citations: 1)

Topoisomerase II alpha gene copy loss has adverse prognostic significance in ERBB2-amplified breast cancer: a retrospective study of paraffin-embedded tumor specimens and medical charts (Citations: 2)

Effects ofERBB2 amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancer (Citations: 4)

Biclonal Breast Carcinoma Metastatic to a Supraclavicular Lymph Node

Identification of downstream targets of the putative tumor suppressor gene on 8p by differential gene expression analysis (Citations: 1)

Citations (9 times by 9 publications)

Formation and interpretation of the BMP morphogen gradient in the Drosophila embryo

Topoisomerase 2 Alpha and the Case for Individualized Breast Cancer Therapy (Citations: 1)

Clinical evaluation of developed PCR-based method with hydrolysis probes for TOP2A copy number evaluation in breast cancer samples

GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer (Citations: 18)

Predicting the efficacy of trastuzumab-based therapy in breast cancer: Current standards and future strategies (Citations: 12)


	View FAQ about top research areas and Fields of study

Co-authors (30)

Journals (6)

Keywords (18)

Lydia Usha,Rush University Medical Center,Oncology,Genetics & Genealogy,Anatomy

Publications (6) BibTeX | RIS | RefWorks Download

A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies (Citations: 1)

Topoisomerase II alpha gene copy loss has adverse prognostic significance in ERBB2-amplified breast cancer: a retrospective study of paraffin-embedded tumor specimens and medical charts (Citations: 2)

Effects ofERBB2 amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancer (Citations: 4)

Biclonal Breast Carcinoma Metastatic to a Supraclavicular Lymph Node

Identification of downstream targets of the putative tumor suppressor gene on 8p by differential gene expression analysis (Citations: 1)

Citations (9 times by 9 publications)

Formation and interpretation of the BMP morphogen gradient in the Drosophila embryo

Topoisomerase 2 Alpha and the Case for Individualized Breast Cancer Therapy (Citations: 1)

Clinical evaluation of developed PCR-based method with hydrolysis probes for TOP2A copy number evaluation in breast cancer samples

GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer (Citations: 18)

Predicting the efficacy of trastuzumab-based therapy in breast cancer: Current standards and future strategies (Citations: 12)

Publications (6)

BibTeX | RIS | RefWorks Download